The Antibody Drug Conjugates Market is estimated to be valued at US$ 5.38 billion in 2023 and is expected to exhibit a CAGR of 14.2% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Antibody drug conjugates (ADCs) are monoclonal antibodies linked to cytotoxic agents. They specifically deliver chemotherapy agents to cancer cells, minimizing toxicity ... Read more

Antibody drug conjugates are biopharmaceutical compounds comprising a monoclonal antibody joined to a biologically active cytotoxic drug or cytotoxic agent. Unlike traditional chemotherapy, ADCs are designed to directly deliver cell-killing agents specifically to tumor cells while leaving healthy cells alone. This allows ADCs to eradicate cancerous cells while minimizing unwanted side effects in healthy tissues.

The global Antibody Drug Conjugates Market is estimated to be valued at ... Read more